Cambridge, MA – Nuclea Biotechnologies, Inc. today announced that it will begin offering more than fifty research use only (RUO) mass spectrometry-based biomarker tests as part of their laboratory services. At the American Association of Clinical Chemistry (AACC)’s annual conference, Nuclea will highlight their new service offering available in addition to their CLIA/CAP certified labs. […]
ATLANTA — Clinical chemistry and manufacturing laboratories performing quality control (QC) will now have relief from QC standard lot changes for up to five years. The Thermo Scientific MAS Liquimmune controls are designed to monitor immunoassay test procedures on automated instruments, and the analytes covered include those routinely measured for fertility, thyroid, iron deficiency, endocrine […]
ATLANTA, GA – AACC 2015 – Clinical laboratories requiring high-throughput separations for their LC-MS assays now have access to a new four-channel, high-performance liquid chromatography (HPLC) system designed to increase the productivity and efficiency of clinical sample separations, while freeing valuable bench space. Listed with the FDA as a Class I medical device for general […]
ATLANTA — Clinical laboratories performing immunodiagnostic testing now have a wider array of solutions to aid in the diagnosis of allergy and autoimmune diseases. The Phadia™ 2500E Laboratory System, ImmunoCAP™ Allergen Components (currently under FDA review) for Hazelnut, Walnut, and Cashew Nut, and EliA™ PR3s, MPOs and GBM Assays (recently FDA Cleared) make their debut […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its has again achieved ISO 13485:2003 certification for the design, manufacture, and distribution of instruments, software, reagents and test kits used in the analysis of gene expression. The re-certification covers the design, development, production, […]
SEATTLE, WA — Atossa Genetics Inc. (NASDAQ: ATOS) today announced that its subsidiary, The National Reference Laboratory for Breast Health Inc. (the NRLBH), now provides a new expanded pharmacogenetic test based on technology and equipment provided by Luminex Corporation (NASDAQ: LMNX). The NRLBH is the first commercial laboratory to develop and now offer the new […]
Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s […]
Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® HSV 1&2
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received FDA clearance for two new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2), to be run on its illumigene® molecular platform. The illumigene® HSV 1&2 assays, launched earlier this year in Europe, are now […]
Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s […]
Vancouver, BC –– Contextual Genomics, developers of genomics-based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based medicine to Canadians, are pleased to announce global sequencing technology leader, Illumina, Inc. has joined its National Access Project consortium. The National Access Project aims to make genomics testing a standard practice in cancer care […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
